Schedule 13G ownership disclosure

ADC THERAPEUTICS SA

Common Shares, par value CHF 0.08 per share · CUSIP: H0036K147

Event date: 2026-10-22

Filing-level shares
14,825,625
Percent of class
9.99%
  • Bain Capital Life Sciences Opportunities IV, L.P.

    Shares: 14,825,625 · Class: 9.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-26-438199
Form type
SCHEDULE 13G
Filer
Bain Capital Life Sciences Opportunities IV, L.P.
CIK
CIK 2015553
Filed
Oct 29, 2026
Reporting period
Oct 22, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub